Vivanza Biosciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vivanza Biosciences Ltd. on BSE

Load latest

Vivanza Biosciences Ltd.

01 Feb 2025

2.07

4.55%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015-Publication of Financial Results for the Quarter & Nine months ended 31st December, 2024

pdf

Vivanza Biosciences Ltd.

31 Jan 2025

2.07

4.55%

Company Update

Vivanza Biosciences Ltd - 530057 - Outcome Of The Board Meeting.

BSE India

Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. to consider and approve the Un-audited Financial Results for the Quarter and Nine months ended 31st December, 2024.

pdf

Vivanza Biosciences Ltd.

31 Jan 2025

2.07

4.55%

Result

Vivanza Biosciences Ltd - 530057 - Results For Quarter And Nine Months Ended 31St December, 2024

BSE India

Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2024.

pdf

Vivanza Biosciences Ltd.

30 Jan 2025

2.07

4.55%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015.

pdf

Vivanza Biosciences Ltd.

24 Jan 2025

2.07

4.55%

Board Meeting

Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Intimation Under Regulation 29(1)(A) And Regulation …

BSE India

Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December, 2024; 2. Any other business with the permission of Chairman.

pdf

Vivanza Biosciences Ltd.

15 Jan 2025

2.07

4.55%

Company Update

Vivanza Biosciences Ltd - 530057 - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 …

BSE India

Non-Applicability of Statement of Deviation or variation under Regulation 32 of SEBI (LODR) Regulations, 2015.

pdf

Vivanza Biosciences Ltd.

11 Jan 2025

2.07

4.55%

Company Update

Vivanza Biosciences Ltd - 530057 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31st December, 2024.

pdf

Vivanza Biosciences Ltd.

27 Dec 2024

2.07

4.55%

SAST

Vivanza Biosciences Ltd - 530057 - Closure of Trading Window

BSE India

Intimation of Closure of Trading Window

pdf

Vivanza Biosciences Ltd.

20 Dec 2024

2.07

4.55%

SAST

Vivanza Biosciences Ltd - 530057 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parth H Parikh

pdf

Vivanza Biosciences Ltd.

11 Dec 2024

2.07

4.55%

SAST

Vivanza Biosciences Ltd - 530057 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Parth H Parikh

pdf

Is Vivanza Biosciences Ltd. worth buying?

26 Votes:

Buy 61.54%

Sell 15.38%

Hold 23.08%